Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
Azacitidine salvage therapy for relapse of myeloid malignancies following allogeneic hematopoietic SCT
Azacitidine in untreated acute myeloid leukemia: A report on 149 patients
Azacyclo-auxiliary ligand-tuned SMMs of dibenzoylmethane Dy(III) complexes
Azacyclic FTY720 Analogues That Limit Nutrient Transporter Expression but Lack S1P Receptor Activity and Negative Chronotropic Effects Offer a Novel and Effective Strategy to Kill Cancer Cells in Vivo
Azacalix[2]arene[2]carbazoles: synthesis, structure and properties
Azacitidine in combination with intensive induction chemotherapy in older patients with acute myeloid leukemia: The AML-AZA trial of the study alliance leukemia
Azacitidine with or without Entinostat for the treatment of therapy-related myeloid neoplasm: further results of the E1905 North American Leukemia Intergroup study
Azacitidine and Sorafenib Therapy in a Pediatric Patient With Refractory Acute Myeloid Leukemia With Monosomy 7 and Somatic PTPN11 Mutation
Azacitidine Pre-Treatment Followed by Reduced-Intensity Stem Cell Transplantation in Patients with Higher-Risk Myelodysplastic Syndrome
Azacitidine frontline therapy for unfit acute myeloid leukemia patients: Clinical use and outcome prediction
Azacitidine treatment for patients with myelodysplastic syndrome and acute myeloid leukemia with chromosome 3q abnormalities
Azacitidine for the treatment of relapsed and refractory AML in older patients
Azacytidine treatment after discontinuation of immunosuppressants in patients with myelodysplastic syndrome and relapse after allo-SCT at a single center
Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia
Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia
Azacytidine induces cell cycle arrest and suppression of neuroendocrine markers in carcinoids
Azacitidine for treatment of patients with myelodysplastic syndromes (MDS): practical recommendations of the German MDS Study Group
Azacitidine for the Treatment of Lower Risk Myelodysplastic Syndromes
Azacytidine mitigates experimental sclerodermic chronic graft-versus-host disease
Azacitidine-lenalidomide (ViLen) combination yields a high response rate in higher risk myelodysplastic syndromes (MDS)-ViLen-01 protocol
Azacitidine in the treatment of blastic plasmacytoid dendritic cell neoplasm: a report of 3 cases
Azacitidine in the Front-line Treatment of Therapy-related Myeloid Neoplasms: A Multicenter Case Series
Azacitidine A Review of its Use in the Management of Myelodysplastic Syndromes/Acute Myeloid Leukaemia
Azacitidine A Review of its Use in Higher-Risk Myelodysplastic Syndromes/Acute Myeloid Leukaemia
Azacalix[4]arene tetramethyl ether with inherent chirality generated by substitution on the nitrogen bridges
Azacalix[7]arene heptamethyl ether: Preparation, nanochannel crystal structure, and selective adsorption of carbon dioxide
Azacrown-attached meta-ethynylpyridine polymer: saccharide recognition regulated by supramolecular device
Azacrown Ethers from Mustard Carbonate Analogues
Azacytidine and Decitabine Induce Gene-Specific and Non-Random DNA Demethylation in Human Cancer Cell Lines
Azachalcones: A new class of potent polyphenol oxidase inhibitors
Azacalix[3]arene-carbazole conjugated polymer network ultrathin films for specific cation sensing
Azacytidine and erlotinib exert synergistic effects against acute myeloid leukemia
Azacitidine and the beginnings of therapeutic epigenetic modulation
Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models
Azacalix[6]arene hexamethyl ether: Synthesis, structure, and selective uptake of carbon dioxide in the solid state
Azacitidine differentially affects CD4(pos) T-cell polarization in vitro and in vivo in high risk myelodysplastic syndromes
Azacytidine as a novel agent in the treatment of acute lymphoblastic leukemia
Azacytidine impairs NK cell reactivity while decitabine augments NK cell responsiveness toward stimulation
Azacycloalkanes from epoxides and aziridines
Azacitidine induces demethylation of p16INK4a and inhibits growth in adult T-cell leukemia/lymphoma
Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML)
Azacrown-oxabridged macrocycle: a novel hybrid fluorogenic chemosensor for transition and heavy metal ions
Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group
Azacytidine-induced Chemosensitivity to Doxorubicin in Human Breast Cancer MCF7 Cells
Azacitidine Mitigates Graft-versus-Host Disease via Differential Effects on the Proliferation of T Effectors and Natural Regulatory T Cells In Vivo
Azacytidine Treatment Inhibits the Progression of Herpes Stromal Keratitis by Enhancing Regulatory T Cell Function
Azacytidine and miR156 promote rooting in adult but not in juvenile Arabidopsis tissues
Azacitidine as a bridge to allogeneic hematopoietic cell transplantation in a pediatric patient with Fanconi anemia and acute myeloid leukemia
Azacitidine improves the T-cell repertoire in patients with myelodysplastic syndromes and acute myeloid leukemia with multilineage dysplasia
Azacytidine for the treatment of retrospective analysis from the Gruppo Laziale for the study of Ph-negative MPN
Azacitidine and Allogeneic Stem Cell Transplantation: When and Why?
Azacitidine in the treatment of older patients affected by acute myeloid leukemia: A report by the Rete Ematologica Pugliese (REP)
Azacitidine Use After Allogeneic Stem Cell Transplantation-Results From the Polish Adult Leukemia Group
Azacitidine in adult patients with acute myeloid leukemia
Azacitidine successfully maintained the second remission in an infant with KMT2A-rearranged acute lymphoblastic leukemia who relapsed after unrelated cord blood transplantation
Azacitidine-associated Sweet%26apos;s syndrome
Azacitidine favorably modulates PSA kinetics correlating with plasma DNA LINE-1 hypomethylation in men with chemonaive castration-resistant prostate cancer
Azacitidine in the treatment of extramedullary relapse of AML after allogeneic hematopoietic cell transplantation
Azacitidine-Induced Pericarditis: A Case Series
Azacitidine-resistant SKM1 myeloid cells are defective for AZA-induced mitochondrial apoptosis and autophagy
Azacitidine combined with gemtuzumab ozogamicin in patients with relapsed/refractory acute myeloid leukemia
Azacitidine for the treatment of patients with acute myeloid leukemia
Azacitidine in a patient with myelodysplastic syndrome: Impact of switching from a 5-day to the approved 7-day dosing schedule
Azacitidine has limited activity in %26apos;real life%26apos; patients with MDS and AML: a single centre experience
Azacitidine-Induced Pneumonitis in a Patient with Myelodysplastic Syndrome: First Case Report in Japan
Azacitidine in a patient with newly diagnosed acute myeloid leukemia and poor risk cytogenetics: Outcomes of prolonged therapy
Azacitidine: A Review in Myelodysplastic Syndromes and Acute Myeloid Leukaemia
Azacytidine impairs NK cell activity in AML and MDS patients undergoing MRD-based pre-emptive treatment after allogeneic stem cell transplantation
Azacitidine-associated Acute Interstitial Pneumonitis
Azacoccones A - E, five new aza-epicoccone derivatives from Aspergillus flavipes
Azacryptands as molecular cages for anions and metal ions
Azacitidine improves outcome in higher-risk MDS patients with chromosome 7 abnormalities: a retrospective comparison of GESMD and GFM registries
Azacitidine in Lower-Risk Myelodysplastic Syndromes: AMeta-Analysis of Data from Prospective Studies
Azacytidine in combination with tyrosine kinase inhibitors induced durable responses in patients with advanced phase chronic myelogenous leukemia
Azacitidine or intensive chemotherapy for older patients with secondary or therapy-related acute myeloid leukemia
Azadirachta Indica Extracts as Corrosion Inhibitor for Mild Steel in Acid Medium
Azadirachtin-based insecticides induce alteration in Helicoverpa armigera Hub. head polypeptides
Azadirachta indica Attenuates Colonic Mucosal Damage in Experimental Colitis Induced by Trinitrobenzene Sulfonic Acid
Azadinium dalianense, a new dinoflagellate species from the Yellow Sea, China
Azadirachtin-mediated reproductive response of the predatory pirate bug Blaptostethus pallescens
Azadipyrromethene-Based Zn(II) Complexes as Nonplanar Conjugated Electron Acceptors for Organic Photovoltaics
Azadirachtin avoidance by larvae and adult females of the tomato leafminer Tutu absoluta
Azadirone, a Limonoid Tetranortriterpene, Induces Death Receptors and Sensitizes Human Cancer Cells to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) through a p53 Protein-independent Mechanism EVIDENCE FOR THE ROLE OF THE ROS-ERK-CHOP-DEATH RECEPTOR PATHWAY